Skip to main content
BioPharma Credit PLC (LON:BPCR)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.930
-0.010 (-1.06%)
At close: Mar 6, 2026

BioPharma Credit Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Other Revenue
154.66150.03135.74218.17103.88110.02
Upgrade
Revenue
154.66150.03135.74218.17103.88110.02
Upgrade
Revenue Growth (YoY)
13.42%10.53%-37.78%110.02%-5.58%-27.09%
Upgrade
Gross Profit
154.66150.03135.74218.17103.88110.02
Upgrade
Selling, General & Admin
31.6527.7227.2835.7918.9520.87
Upgrade
Other Operating Expenses
-0.080.1300.04-0.05-
Upgrade
Operating Expenses
31.5627.8527.2835.8318.920.87
Upgrade
Operating Income
123.1122.18108.46182.3484.9889.15
Upgrade
Currency Exchange Gain (Loss)
0.02-0-0.01-0.03-0.02-0.01
Upgrade
Pretax Income
123.12122.18108.45182.3184.9689.14
Upgrade
Net Income
123.12122.18108.45182.3184.9689.14
Upgrade
Net Income to Common
123.12122.18108.45182.3184.9689.14
Upgrade
Net Income Growth
12.58%12.66%-40.51%114.59%-4.69%-27.13%
Upgrade
Shares Outstanding (Basic)
1,1741,2221,3091,3641,3741,374
Upgrade
Shares Outstanding (Diluted)
1,1741,2221,3091,3641,3741,374
Upgrade
Shares Change (YoY)
-7.85%-6.65%-4.00%-0.72%-0.00%-0.00%
Upgrade
EPS (Basic)
0.100.100.080.130.060.06
Upgrade
EPS (Diluted)
0.100.100.080.130.060.06
Upgrade
EPS Growth
22.17%20.68%-38.03%116.14%-4.68%-27.13%
Upgrade
Dividend Per Share
0.0700.0700.0700.0700.0700.070
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
79.59%81.44%79.90%83.58%81.80%81.03%
Upgrade
Profit Margin
79.61%81.44%79.90%83.56%81.79%81.02%
Upgrade
EBIT
123.1122.18108.46182.3484.9889.15
Upgrade
EBIT Margin
79.59%81.44%79.90%83.58%81.80%81.03%
Upgrade
Revenue as Reported
154.69150.03135.73218.14103.86110.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.